Notice

This is not the latest version of this item. The latest version can be found at:https://dspace.mit.edu/handle/1721.1/138388.2

CRISPR-Based Therapeutic Genome Editing: Strategies and In Vivo Delivery by AAV Vectors

Author(s)
Wang, D; Zhang, F; Gao, G
Thumbnail
DownloadAccepted version (965.0Kb)
Publisher with Creative Commons License
Terms of use
Creative Commons Attribution-NonCommercial-NoDerivs License http://creativecommons.org/licenses/by-nc-nd/4.0/
Metadata
Show full item record
Abstract
© 2020 Elsevier Inc. Wang, Zhang, and Gao discuss the progress, concerns, and challenges currently facing CRISPR-based therapeutics, a field that has inspired renewed but cautious interest in human genome editing.
Date issued
2020-04-02
URI
https://hdl.handle.net/1721.1/138388
Journal
Cell
Publisher
Elsevier BV
Citation
Wang, D, Zhang, F and Gao, G. 2020. "CRISPR-Based Therapeutic Genome Editing: Strategies and In Vivo Delivery by AAV Vectors." Cell, 181 (1).
Version: Author's final manuscript
Collections

Version History

VersionItemDateSummary
21721.1/138388.22022-05-16T19:29:49ZPublication information verified/added.
11721.1/138388*2021-12-08T18:08:11Z

*Selected version